Near Infrared Imaging: Dye injected into or around tumor at the time of surgery
Study summary
The primary purpose of this study is to determine if we can identify the first lymph node that drains from the tumor, and thus would be the most likely site for metastatic disease, and remove it for analysis to improve the ability to detect tumor in this node and to remove this additional site that potentially contains tumor cells.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Suspected or histologically documented new non-small cell carcinoma that have agreed to undergo a thoracotomy for segmentectomy, lobectomy, bilobectomy or pneumonectomy as recommended by their thoracic surgeon for treatment
* Surgically resectable lung cancer
* N2 lymph nodes negative on PET scan or mediastinoscopy
* Age \> or equal to 18 years of age
* Men, women of non-child bearing age or women with a negative pregnancy test
Exclusion Criteria:
* Patient does not want to undergo subsequent surgical resection
* Medical condition such as uncontrolled infection or cardiac disease that, i the opinion of the treating surgeon, makes resection unreasonably hazardous for the patient.
* T4 or N2 disease
* Pre-operative spirometry that suggests they cannot undergo resection of their primary tumor by segmentectomy, lobectomy, bilobectomy, or pneumonectomy
* Iodide or seafood allergy
* Pregnant or lactating women
Primary outcome measure(s)
To evaluate the safety and efficacy of near-infrared technology to guide therapeutic sentinel lymph node dissection in patients with lung cancer. — 3 years
Trial sites (4)
Facility
City
Region
Status
Massachusetts General Hospital
Boston
Massachusetts
Beth Israel Deaconess Medical Center
Boston
Massachusetts
Brigham and Women's Hospital
Boston
Massachusetts
Dana-Farber Cancer Institute
Boston
Massachusetts
More Dana-Farber Cancer Institute trials in Israel
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.